SCHEMBL6988021

SCHEMBL6988021

CN(C)c1ccc(C(=O)NCC(C(=O)NC23CCCC2OCC3=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
UTS2R Q9UKP6 1/20 0.38
TP53 P04637 9/20 0.38
MAPT P10636 7/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989694 0.93 KMT2A (0.40) NPC1HPGDKMT2ASMN1; SMN2TP53
SCHEMBL6994067 0.92 RAB9A (0.41) NPC1KMT2ASMN1; SMN2TP53LMNA
SCHEMBL6986470 0.91 HPGD (0.38) NPC1HPGDKMT2ASMN1; SMN2TP53
SCHEMBL6989614 0.89 TP53 (0.47) NPC1KMT2ASMN1; SMN2TP53MAPT
SCHEMBL6990244 0.88 TP53 (0.38) KMT2AUTS2RTP53MAPTPOLB
SCHEMBL6993839 0.86 HTR1A (0.39) NPC1HPGDKMT2ASMN1; SMN2TP53
SCHEMBL6988915 0.85 IDO1 (0.42) NPC1KMT2ASMN1; SMN2TP53LMNA
SCHEMBL6991739 0.85 TRPV1 (0.38) TP53LMNA
SCHEMBL6988745 0.85 CTSK (0.35) NPC1HPGDKMT2ASMN1; SMN2MAPT
SCHEMBL6992764 0.83 HPGD (0.39) NPC1HPGDKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1358176-A2 INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-05 EP disclosed
WO-2002057246-A2 INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed